In contrast, IDH2 mutations were reported as IDH2-R172K (20/31: 64.5%), IDH2-R172M (6/31: 19.3%), and IDH2-R172W (5/31: 16.2%) in gliomas [13]. Here, IDH2 is linked to glioma.